P3 Health Partners Inc.
PIII
$9.80
$0.717.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 355.79M | 373.23M | 370.69M | 362.12M | 379.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 355.79M | 373.23M | 370.69M | 362.12M | 379.16M |
| Cost of Revenue | 351.35M | 372.04M | 410.22M | 401.92M | 365.17M |
| Gross Profit | 4.44M | 1.18M | -39.54M | -39.80M | 13.99M |
| SG&A Expenses | 23.45M | 25.18M | 31.83M | 33.55M | 27.02M |
| Depreciation & Amortization | 21.08M | 21.05M | 21.15M | 21.67M | 21.69M |
| Other Operating Expenses | -5.97M | -6.96M | 37.93M | 18.17M | -3.40M |
| Total Operating Expenses | 389.91M | 411.31M | 501.13M | 475.31M | 410.49M |
| Operating Income | -34.12M | -38.09M | -130.45M | -113.19M | -31.33M |
| Income Before Tax | -41.68M | -43.17M | -124.20M | -106.46M | -27.81M |
| Income Tax Expenses | 1.98M | 1.07M | 4.95M | -3.61M | 968.00K |
| Earnings from Continuing Operations | -43.67M | -44.25M | -129.15M | -102.85M | -28.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.30M | 23.77M | 70.53M | 56.34M | 16.75M |
| Net Income | -20.36M | -20.48M | -58.62M | -46.51M | -12.02M |
| EBIT | -34.12M | -38.09M | -130.45M | -113.19M | -31.33M |
| EBITDA | -13.04M | -17.04M | -109.29M | -91.52M | -9.64M |
| EPS Basic | -6.23 | -6.28 | -25.14 | -14.37 | -4.40 |
| Normalized Basic EPS | -0.84 | -0.99 | -4.44 | -4.35 | -0.23 |
| EPS Diluted | -6.23 | -6.28 | -29.04 | -15.70 | -7.37 |
| Normalized Diluted EPS | -0.84 | -0.99 | -4.44 | -4.27 | -0.22 |
| Average Basic Shares Outstanding | 3.27M | 3.26M | 2.33M | 3.24M | 2.73M |
| Average Diluted Shares Outstanding | 3.27M | 3.26M | 2.33M | 3.29M | 2.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |